Analyst consensus rating
RenovoRx, Inc. Analyst Consensus Rating
RNXT analyst consensus rating, coverage count and price target evidence.
Direct answer
RenovoRx, Inc.'s consensus rating is Strong Buy.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $7.03.
Forecast evidence checked August 12, 2026.
Get free RenovoRx, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.15
- Average price target
- $7.03
- High price target
- $14.00
- Low price target
- $3.00
- Target upside
- +511.3%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- August 12, 2026
- Valid through
- August 19, 2026